• Most Popular
  • Most Shared

Neurobiological Technologies gets Memantine royalty of $2.1 mln

Wed Feb 20, 2008 7:18am EST

Feb 20 (Reuters) - Drug development company Neurobiological Technologies Inc NTII.O said it got about $2.1 million in royalty payments on sales of Memantine, a treatment for Alzheimer's disease, for the quarter ended Sept. 30, 2007.

Under an exclusive marketing agreement, the company receives quarterly royalty payments on sales of Memantine from Merz Pharmaceuticals GmbH and its marketing partners. (Reporting by Manish Gupta in Bangalore; Editing by Pratish Narayanan)



More from Reuters

New home sales hit seven-month low

WASHINGTON (Reuters) - Sales of newly built U.S. single-family homes unexpectedly fell to their lowest level in seven months in November, data showed on Wednesday, dealing a blow to the housing market's recovery.

» More Top News
Malaysians participate in computer attack and defence hacking competition during The 3rd Annual Hack-In-The-Box Security Conference 2004 in Kuala Lumpur on October 6, 2004. REUTERS/Bazuki Muhammad
Commentary:

Year of the breach

Data security breaches are nasty business and should be avoided at all costs, writes Kevin Prince, a chief technology officer at Perimeter e-Security. Here's a look at the biggest breaches and blunders of 2009.  Commentary 

Technology
Cannabis sativa plant is seen in Buenos Aires, August 21, 2009. REUTERS/Enrique Marcarian
Commentary:

Obama, drugs, common sense

American attitudes towards drug prohibition – and above all, punitive laws on marijuana – are changing too fast for policymakers and legislators to ignore, writes columnist Bernd Debusmann.  Commentary 

U.S.